A
Alan D. Tice
Researcher at University of Hawaii at Manoa
Publications - 83
Citations - 4895
Alan D. Tice is an academic researcher from University of Hawaii at Manoa. The author has contributed to research in topics: Health care & Methicillin-resistant Staphylococcus aureus. The author has an hindex of 31, co-authored 83 publications receiving 4628 citations. Previous affiliations of Alan D. Tice include University of Washington.
Papers
More filters
Journal ArticleDOI
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Vance G. Fowler,Helen W. Boucher,G. Ralph Corey,Elias Abrutyn,Adolf W. Karchmer,Mark E. Rupp,Donald P. Levine,Henry F. Chambers,Francis P. Tally,Gloria Vigliani,Christopher H. Cabell,Arthur Stanley Link,Ignace DeMeyer,Scott G. Filler,Marcus J. Zervos,Paul P. Cook,Jeffrey Parsonnet,Jack M. Bernstein,Connie S. Price,Graeme N. Forrest,Gerd Fätkenheuer,Marcelo Gareca,Susan J. Rehm,Hans Reinhardt Brodt,Alan D. Tice,Sara E. Cosgrove +25 more
TL;DR: Daptomycin (6 mg per kilogram daily) is not inferior to standard therapy for S. aureus bacteremia and right-sided endocarditis and met prespecified criteria for the noninferiority of daptomecin.
Journal ArticleDOI
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Alan D. Tice,Susan J. Rehm,Joseph R. Dalovisio,John S. Bradley,Lawrence P. Martinelli,Donald R. Graham,R. Brooks Gainer,Mark J. Kunkel,Robert W. Yancey,David N. Williams +9 more
TL;DR: These guidelines were formulated to assist physicians and other health care professionals with various aspects of the administration of outpatient parenteral antimicrobial therapy (OPAT).
Journal ArticleDOI
Managing skin and soft tissue infections: expert panel recommendations on key decision points
Lawrence J. Eron,Benjamin A. Lipsky,Donald E. Low,Dilip Nathwani,Alan D. Tice,Gregory A. Volturo +5 more
Journal ArticleDOI
Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial
Benjamin A. Lipsky,David G. Armstrong,Diane M. Citron,Alan D. Tice,David Morgenstern,Murray A. Abramson +5 more
TL;DR: Clinical and microbiological outcomes for patients treated with ertapenem were equivalent to those for patientstreated with piperacillin/tazobactam, suggesting that this once-daily antibiotic should be considered for parenteral therapy of diabetic foot infections, when deemed appropriate.
Journal ArticleDOI
Risk factors and treatment outcomes in osteomyelitis
TL;DR: Osteomyelitis caused by Pseudomonas aeruginosa was associated with more than a two-fold increase in recurrence, and treatment with ceftriaxone was as effective as the penicillinase-resistant penicillins and cefazolin.